ICOS Antikörper (Cy7,PE)

Produktnummer ABIN476816

Dieser Maus Monoklonal Antikörper erkennt spezifisch ICOS in FACS. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für ICOS Antikörper (Cy7,PE) (ABIN476816)

Target: ICOS (Inducible T-Cell Co-Stimulator (ICOS))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser ICOS Antikörper ist konjugiert mit Cy7,PE

Applikation: Flow Cytometry (FACS)

Klon: ISA-3

Produktdetails anti-ICOS Antikörper (Cy7,PE)

Aufreinigung: Affinity purified

Immunogen: Human ICOS

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Approved: Flo

Usage: This ISA-3 antibody has been pre-titrated and tested by flow cytometric analysis of stimulated normal human peripheral blood cells. This can be used at 5 μL (0.125 μg)/per test. A test is defined as the amount (ug)/test of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Aqueous buffer, 0.09 % sodium azide, contains stabilizer if necessary

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Do not freeze. Product is photosensitive and should be protected from light.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 4°C. Do not freeze. Protect from light.

Details zu ICOS

Target: ICOS (Inducible T-Cell Co-Stimulator (ICOS))

Andere Bezeichnung: ICOS / CD278

Hintergrund: Name/Gene ID: ICOS

Synonyms: ICOS, AILIM, CD278, CVID1, Inducible costimulator, Inducible T-cell co-stimulator, CD278 antigen, Inducible T-cell costimulator

Gen-ID: 29851

UniProt: Q9Y6W8

Pathways: Cancer Immune Checkpoints